Alnylam Pharmaceuticals | Créanciers Commerciaux



Trade Creditors Changement Date
Acadia Pharmaceuticals USD 16.19M 2.89M 2024-12
Agios Pharmaceuticals USD 16.64M 500K 2024-12
Alnylam Pharmaceuticals USD 88.42M 17.61M 2024-12
Amgen USD 1.91B 239M 2024-12
Arrowhead Research USD 14.46M 3.07M 2024-12
BioMarin Pharmaceutical 235.4M 480.26M 2024-12
Incyte USD 195.54M 1.93M 2025-03
Ionis Pharmaceuticals USD 17.46M 25.51M 2025-03
Moderna USD 226M 179M 2025-03
Neurocrine Biosciences 110M 282.7M 2024-12
Novartis USD 4.57B 485M 2024-12
PTC Therapeutics USD 17.27M 3.98M 2024-12
Regeneron Pharmaceuticals USD 705.5M 4.18B 2025-03
Sanofi 7.55B 118M 2024-12
Sarepta Therapeutics USD 214.44M 95.67M 2024-12
Takeda JPY 460.18B 46.85B 2024-12
Tectonic Therapeutic USD 976K 1.66M 2024-12
Ultragenyx Pharmaceutical USD 38.76M 2.77M 2024-12
Vertex Pharmaceuticals USD 413M 17.2M 2024-12
Xencor USD 16.76M 2.01M 2024-12



Alnylam Pharmaceuticals Créanciers Commerciaux - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.